VBID® Newsletter > February 2018
VBID® Newsletter - February 2018
Focus of the Week
October 26, 2017 – Mary Caffrey
While Congress debates the fate of the Affordable Care Act, healthcare transformation continues, as seen in an update released this week at Horizon Blue Cross Blue Shield of New Jersey.
May 17, 2017 – Surabhi Dangi-Garimella, PhD
With growing competition, rising drug prices, and the broad generics market, stakeholders are demanding measurable “value” in medicinal products.
September 12, 2017 – Laura Joszt
As the healthcare industry struggles to address rising costs and unaffordable care, attention is turning to value-based benefit design options. Altarum has released its outline for a new value-based insurance design model that it will test at pilot sites across the country.
January 06, 2018 – Kaitlynn Ely
New drugs to treat multiple myeloma (MM) have provided clinical benefits, but a study published in the Journal of Managed Care & Specialty Pharmacy found not all of them can be considered cost effective.
January 10, 2018 – Mary Caffrey
The announcement comes after CMS canceled an Obama-era proposal for mandatory bundled payments in cardiac care, as well as a mandatory expansion of a program in joint replacements.
January 21, 2018 – Kaitlynn Ely
Patients dually enrolled in Medicare and Medicaid have higher levels of Medicare spending compared to other beneficiaries, and it can impact hospitals' performance on a Medicare cost measure, according to a study published in Health Affairs.